Sunshine Biopharma (SBFM) Shares Outstanding (Diluted Average) (2021 - 2025)

Sunshine Biopharma has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $2.7 million in Q1 2025.

• For the quarter ending Q1 2025, Shares Outstanding (Diluted Average) rose 321.53% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2025 stood at $2.7 million (up 321.53% YoY), and the FY2024 full-year result was $701749.0, up 5371.73% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2025 stood at $2.7 million, up from $701749.0 in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $25.7 million in Q3 2023, with the low at $12825.0 in Q4 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $8.9 million across 5 years, with a median of $4.0 million in 2022.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) tumbled 99.92% — and 2024, when it soared 5371.73%.
• Sunshine Biopharma's Shares Outstanding (Diluted Average) stood at $2.6 million in 2021, then surged by 481.18% to $15.2 million in 2022, then plunged by 99.92% to $12825.0 in 2023, then soared by 5371.73% to $701749.0 in 2024, then jumped by 285.22% to $2.7 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $2.7 million (Q1 2025), $701749.0 (Q4 2024), and $641310.0 (Q1 2024), per Business Quant data.